| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 365-374, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
RK Singh, CD Bucana, M Gutman, D Fan, MR Wilson and IJ Fidler
Department of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
We investigated the influence of organ microenvironment on the angiogenic phenotype in human renal cell carcinoma (HRCC) cells. HRCC line SN12C was established in vitro from a surgical specimen, and metastatic line SN12PM6 was isolated from a lung metastasis produced by parental cells implanted into the kidney of nude mice. SN12C (low metastasis) and SN12PM6 (high metastasis) cells were injected into the kidney or subcutis of nude mice. The kidney tumors were highly vascularized (as revealed by immunohistochemistry using antibodies against factor VIII), and metastatic, whereas the subcutaneous tumors were not. The expression of mRNA for basic fibroblast growth factor (bFGF) in kidney tumors was 10 to 20 times that found in subcutaneous tumors. Similar data were obtained at the protein level by using fluorescence activated cell sorting, immunohistochemistry, and enzyme- linked immunosorbent assay. bFGF was detected in the urine of mice with tumors in the kidney but not subcutaneous tumors. The level of bFGF in the serum of mice with kidney tumors was two to three times that in mice with subcutaneous tumors. The changes in bFGF expression in the tumors was transient. Collectively, these data indicate that the organ microenvironment can influence the expression level of bFGF in HRCC.
This article has been cited by other articles:
![]() |
R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Esposito, E. Palescandolo, E. P. Spugnini, V. Montesarchio, A. De Luca, I. Cardillo, G. Cortese, A. Baldi, and A. Chirianni Evaluation of Antitumoral Properties of the Protease Inhibitor Indinavir in a Murine Model of Hepatocarcinoma Clin. Cancer Res., April 15, 2006; 12(8): 2634 - 2639. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, Y.-W. Park, B. A. Schiff, D. D. Doan, Y. Yazici, S. A. Jasser, M. Younes, M. Mandal, B. N. Bekele, and J. N. Myers An Orthotopic Model of Anaplastic Thyroid Carcinoma in Athymic Nude Mice Clin. Cancer Res., March 1, 2005; 11(5): 1713 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jussila and K. Alitalo Vascular Growth Factors and Lymphangiogenesis Physiol Rev, July 1, 2002; 82(3): 673 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tedjarati, C. H. Baker, S. Apte, S. Huang, J. K. Wolf, J. J. Killion, and I. J. Fidler Synergistic Therapy of Human Ovarian Carcinoma Implanted Orthotopically in Nude Mice by Optimal Biological Dose of Pegylated Interferon {alpha} Combined with Paclitaxel Clin. Cancer Res., July 1, 2002; 8(7): 2413 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Izawa, P. Sweeney, P. Perrotte, D. Kedar, Z. Dong, J. W. Slaton, T. Karashima, K. Inoue, W. F. Benedict, and C. P. N. Dinney Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by Interferon-{beta} Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis Clin. Cancer Res., April 1, 2002; 8(4): 1258 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Guo, L. Xu, S. Pan, R. A. Brekken, S.-T. Yang, G. B. Whitaker, M. Nagane, P. E. Thorpe, J. S. Rosenbaum, H.-J. Su Huang, et al. Vascular Endothelial Growth Factor Isoforms Display Distinct Activities in Promoting Tumor Angiogenesis at Different Anatomic Sites Cancer Res., December 1, 2001; 61(23): 8569 - 8577. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Fidler Angiogenic Heterogeneity: Regulation of Neoplastic Angiogenesis by the Organ Microenvironment J Natl Cancer Inst, July 18, 2001; 93(14): 1040 - 1041. [Full Text] [PDF] |
||||
![]() |
J. W. Slaton, K. Inoue, P. Perrotte, A. K. El-Naggar, D. A. Swanson, I. J. Fidler, and C. P. N. Dinney Expression Levels of Genes that Regulate Metastasis and Angiogenesis Correlate with Advanced Pathological Stage of Renal Cell Carcinoma Am. J. Pathol., February 1, 2001; 158(2): 735 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Fidler Regulation of Neoplastic Angiogenesis J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 10 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuniyasu, W. Yasui, H. Shinohara, S. Yano, L. M. Ellis, M. R. Wilson, C. D. Bucana, T. Rikita, E. Tahara, and I. J. Fidler Induction of Angiogenesis by Hyperplastic Colonic Mucosa Adjacent to Colon Cancer Am. J. Pathol., November 1, 2000; 157(5): 1523 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yano, H. Shinohara, R. S. Herbst, H. Kuniyasu, C. D. Bucana, L. M. Ellis, D. W. Davis, D. J. McConkey, and I. J. Fidler Expression of Vascular Endothelial Growth Factor Is Necessary but not Sufficient for Production and Growth of Brain Metastasis Cancer Res., September 1, 2000; 60(17): 4959 - 4967. [Abstract] [Full Text] |
||||
![]() |
F. Bertolini, L. Fusetti, P. Mancuso, A. Gobbi, C. Corsini, P. F. Ferrucci, G. Martinelli, and G. Pruneri Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma Blood, July 1, 2000; 96(1): 282 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuniyasu, P. Troncoso, D. Johnston, C. D. Bucana, E. Tahara, I. J. Fidler, and C. A. Pettaway Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers Clin. Cancer Res., June 1, 2000; 6(6): 2295 - 2308. [Abstract] [Full Text] |
||||
![]() |
T. Aziz, P. Hasleton, A. W. Hann, N. Yonan, A. Deiraniya, and I. V. Hutchinson TRANSFORMING GROWTH FACTOR {beta} IN RELATION TO CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Herbst, S. Yano, H. Kuniyasu, F. R. Khuri, C. D. Bucana, F. Guo, D. Liu, B. Kemp, J. J. Lee, W. K. Hong, et al. Differential Expression of E-cadherin and Type IV Collagenase Genes Predicts Outcome in Patients with Stage I Non-Small Cell Lung Carcinoma Clin. Cancer Res., March 1, 2000; 6(3): 790 - 797. [Abstract] [Full Text] |
||||
![]() |
S. S. Yoon, H. Eto, C.-m. Lin, H. Nakamura, T. M. Pawlik, S. U. Song, and K. K. Tanabe Mouse Endostatin Inhibits the Formation of Lung and Liver Metastases Cancer Res., December 1, 1999; 59(24): 6251 - 6256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Slaton, P. Perrotte, K. Inoue, C. P. N. Dinney, and I. J. Fidler Interferon-{{alpha}}-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule Clin. Cancer Res., October 1, 1999; 5(10): 2726 - 2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rozera, D. Carlei, P. L. Lollini, C. De Giovanni, P. Musiani, E. Di Carlo, F. Belardelli, and M. Ferrantini Interferon (IFN)-ß Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-{alpha} : Differential Effects on Tumorigenicity and Host Response Am. J. Pathol., April 1, 1999; 154(4): 1211 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dong, G. Greene, C. Pettaway, C. P. N. Dinney, I. Eue, W. Lu, C. D. Bucana, M. D. Balbay, D. Bielenberg, and I. J. Fidler Suppression of Angiogenesis, Tumorigenicity, and Metastasis by Human Prostate Cancer Cells Engineered to Produce Interferon-{beta} Cancer Res., February 1, 1999; 59(4): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuniyasu, L. M. Ellis, D. B. Evans, J. L. Abbruzzese, C. J. Fenoglio, C. D. Bucana, K. R. Cleary, E. Tahara, and I. J. Fidler Relative Expression of E-Cadherin and Type IV Collagenase Genes Predicts Disease Outcome in Patients with Resectable Pancreatic Carcinoma Clin. Cancer Res., January 1, 1999; 5(1): 25 - 33. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |